Efanesoctocog alfa
Efanesoctocog alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Efanesoctocog alfa is under investigation in clinical trial NCT04759131 (Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A).
| Trade Name | Efanesoctocog alfa |
| Generic | Efanesoctocog alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Efanesoctocog alfa
